Corona Remedies Limited
₹2,033.70▼ -16.60 (-0.81%)
CORONA·NSE·Healthcare
Market Cap
12447.40 Cr
PE Ratio
67.30
Volume
32,041
Day High - Low
2061.10 - 2021.00
52W High-Low
2270.10 - 1329.32
₹2,033.70▼ -16.60 (-0.81%)
Market Cap12447.40 Cr
PE Ratio67.30
Volume32,041
Day High - Low2061.10 - 2021.00
52W High-Low2270.10 - 1329.32
DocStoX Score
6.4/10
Fair
Fair Value
Sign in to see
ROE
24.80%
Strong
P/E
67.30x
Expensive
Debt / Equity
0.22
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
Day₹2021
₹2061
52W₹1329
₹2270
DocStoX take
Supported by risk (8.7) and growth (7.8), but held back by valuation (0.0). Risk looks strong at 8.7, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence6.4
/10
Fair
Quality
Excellent
ROE 24.8%
Valuation
Expensive
P/E 67.3×
Growth
Strong
Revenue +19.5% 5Y CAGR
Risk
Low risk
D/E 0.22
Momentum
Strong
75% of 52-week range
At a glance
Market Cap
₹12,447 Cr
52W High / Low
₹2270 / ₹1329
Dividend Yield
0.48%
Promoter Holding
69.00%
EPS (TTM)
₹30.22
Book Value
₹121.86
Key highlights
- Capital works hard — ROCE 33%
- Low leverage — D/E 0.22
- Strong returns on equity (25%)
- Valuation is weak (0.0/10)
- Expensive at 67× earnings
4 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore CORONA REMEDIES LIMITED’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
CORONA REMEDIES LIMITED peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDMANIPAL HEALTH ENTERPRI LLAURUS LABS LIMITEDLUPIN LIMITEDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESMAX HEALTHCARE INS LTD
Compare CORONA REMEDIES LIMITED with peers
Related tools & concepts
Value CORONA REMEDIES LIMITED with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing